6-Prenylnaringenin

6-Prenylnaringenin at a Glance

6-Prenylnaringenin (6-PN) is a prenylated flavanone found almost exclusively in hops (Humulus lupulus), and, through them, in beer. Structurally it is the 6-prenyl positional isomer of 8-prenylnaringenin — the same naringenin skeleton carrying the same five-carbon prenyl side-chain, differing only in where that chain attaches to the A-ring. Both isomers form during brewing from the shared chalcone precursor desmethylxanthohumol.

That single positional difference is the whole story of this molecule. 8-PN is one of the most potent phytoestrogens known; 6-PN is not — its estrogen-receptor activity is under 1% of its famous sibling’s ^{1Reference 1Milligan SR et al. · 2000The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoidsView study →}. Because of that, 6-PN is often studied precisely because it does the interesting non-hormonal things — cancer-selective antiproliferation, estrogen-detoxification, antimicrobial synergy — without the estrogenic activity that complicates 8-PN.

The evidence is honest but modest and entirely preclinical: cell-line and mechanistic work, no human trials of the isolated molecule. Toxicity at dietary exposure appears low.

6-Prenylnaringenin vs. 8-Prenylnaringenin

This is the point of the page, so it is worth stating plainly. 6-PN and 8-PN are structural isomers — identical molecular formula, identical parent flavanone (naringenin), identical prenyl group. The prenyl sits on carbon 6 in one and carbon 8 in the other, and that is the only difference.

Biologically the two diverge sharply:

• 8-Prenylnaringenin is a strong, ERα-preferring phytoestrogen — arguably the most potent identified — and is the compound behind the estrogenic, menopause and bone-protective signals attributed to hop extracts ^{1Reference 1Milligan SR et al. · 2000The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoidsView study →}.
• 6-Prenylnaringenin is essentially non-estrogenic: in the same binding assays that flagged 8-PN, 6-PN’s estrogen-receptor activity came in at less than 1% of 8-PN’s ^{1Reference 1Milligan SR et al. · 2000The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoidsView study →}. Its interest lies elsewhere — cancer-cell selectivity, estrogen-metabolism modulation and antimicrobial action.

Practically, this means the two isomers cannot be treated as interchangeable “hop flavonoids.” A source standardised to 8-PN is being standardised for estrogenicity; 6-PN riding along in the same extract contributes a different, non-hormonal pharmacology. When hop products are discussed for hormone-sensitive concerns, it is 8-PN that is doing the estrogenic work — not 6-PN.

What It's Used For

All of the human-relevant pharmacology below is in-vitro or mechanistic. There are no clinical trials of isolated 6-PN, and most figures are cell-culture IC50 values.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Every row here is preclinical, so scores are capped low; read the per-row basis.

01Anticancer / cancer-selective antiproliferationShaky30%In-vitro cell-line IC50s + Kv1.3 channel mechanism; stronger than cisplatin on T-47D ^{2,6Reference 2Bartmańska A et al. · 2018Highly cancer selective antiproliferative activity of natural prenylated flavonoidsView study →Reference 6Teisseyre A et al. · 2018The influence of 6-prenylnaringenin and selected non-prenylated flavonoids on the activity of Kv1.3 channels in human Jurkat T cellsView study →}

02Estrogen detoxification / chemopreventionShaky24%Mechanistic AhR/CYP1A1 estrogen 2-hydroxylation in cells ^{3,4Reference 3Hitzman RT et al. · 2020Hitzman RT, Dunlap TL, Howell CE, Chen SN, Vollmer G, Pauli GF, Bolton JL, Dietz BM (2020). 6-Prenylnaringenin from hops disrupts ERα-mediated downregulation of CYP1A1 to facilitate estrogen detoxification. Chemical Research in Toxicology. https://pubmed.ncbi.nlm.nih.gov/32986415/View study →Reference 4Bolton JL et al. · 2019The multiple biological targets of hops and bioactive compoundsView study →}

03AntimicrobialShaky18%In-vitro antibacterial + reported antibiotic synergy (review-sourced) ^{10Reference 10Tronina T et al. · 2025Tronina T, Bartmańska A, Popłoński J, Rychlicka M, et al. (2025). 6-Prenylnaringenin — its beneficial biological effects and possible applications. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/41226696/View study →}

Mechanisms

The load-bearing contrast is the estrogen-receptor row: 6-PN and 8-PN are the same molecule bar one bond, yet 6-PN’s ER activity is <1% of 8-PN’s — which is exactly why 6-PN is studied for its non-hormonal actions.

Pharmacokinetics

Human pharmacokinetic data come from a study of a standardised hop extract (not isolated 6-PN) in women. Absorbed 6-PN reaches the circulation but is four to five times less bioavailable than 8-PN — mean Cmax on the order of ~480–600 nmol/L versus ~2,250–3,400 nmol/L for 8-PN — while both isomers show long half-lives (>20 h) consistent with enterohepatic recirculation ^{5Reference 5van Breemen RB et al. · 2014Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hopsView study →}. As with other hop prenylflavonoids, free (unconjugated) 6-PN is scarce in blood; most circulates as phase-II conjugates. This poor oral bioavailability is the central caveat over the micromolar in-vitro potencies above — it is not clear those concentrations are achievable systemically ^{5Reference 5van Breemen RB et al. · 2014Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hopsView study →}.

Clinical Trials

There are no clinical trials of isolated 6-prenylnaringenin. Human exposure has been measured only as one analyte within pharmacokinetic studies of whole standardised hop extracts ^{5Reference 5van Breemen RB et al. · 2014Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hopsView study →}; all efficacy evidence is preclinical.

Last checked: July 2026.

Isolate vs. Plant Studies

The mechanistic and antiproliferative work is on the isolated molecule in cell culture — a clarity strength for attributing the effect to 6-PN specifically ^{2,3,6Reference 2Bartmańska A et al. · 2018Highly cancer selective antiproliferative activity of natural prenylated flavonoidsView study →Reference 3Hitzman RT et al. · 2020Hitzman RT, Dunlap TL, Howell CE, Chen SN, Vollmer G, Pauli GF, Bolton JL, Dietz BM (2020). 6-Prenylnaringenin from hops disrupts ERα-mediated downregulation of CYP1A1 to facilitate estrogen detoxification. Chemical Research in Toxicology. https://pubmed.ncbi.nlm.nih.gov/32986415/View study →Reference 6Teisseyre A et al. · 2018The influence of 6-prenylnaringenin and selected non-prenylated flavonoids on the activity of Kv1.3 channels in human Jurkat T cellsView study →}. But the only human data are pharmacokinetic and use a whole standardised hop extract, within which 6-PN is a minor component alongside 8-PN, xanthohumol and isoxanthohumol ^{5Reference 5van Breemen RB et al. · 2014Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hopsView study →}. The menopause/bone reputation of hop products belongs to that extract and, mechanistically, to the estrogenic 8-PN — not to 6-PN, which is essentially non-estrogenic ^{1,7Reference 1Milligan SR et al. · 2000The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoidsView study →Reference 7Effenberger KE et al. · 2005Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogensView study →}. So 6-PN sits in an unusual position: well-characterised as an isolate in vitro, but never tested as an isolate in people.

Prevalence in Nature

6-PN is, for practical purposes, a hops molecule. It occurs in the lupulin glands of hop cones (Humulus lupulus) at low levels — on the order of 0.004% of dry cone weight, rising to roughly 0.17% in concentrated hop CO2 extract ^{10Reference 10Tronina T et al. · 2025Tronina T, Bartmańska A, Popłoński J, Rychlicka M, et al. (2025). 6-Prenylnaringenin — its beneficial biological effects and possible applications. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/41226696/View study →}. Most of the 6-PN people are exposed to is not stored pre-formed but generated during brewing: the chalcone desmethylxanthohumol isomerises and cyclises on wort boiling into a mixture of 6-PN and 8-prenylnaringenin ^{10Reference 10Tronina T et al. · 2025Tronina T, Bartmańska A, Popłoński J, Rychlicka M, et al. (2025). 6-Prenylnaringenin — its beneficial biological effects and possible applications. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/41226696/View study →}. It therefore reaches beer at roughly 1–240 µg/L, varying widely by hop variety and brewing process ^{10Reference 10Tronina T et al. · 2025Tronina T, Bartmańska A, Popłoński J, Rychlicka M, et al. (2025). 6-Prenylnaringenin — its beneficial biological effects and possible applications. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/41226696/View study →}. Analytical surveys of hop-containing supplements have found inconsistent 6-PN content between products, so label claims are unreliable ^{9Reference 9Martinez SE · 2015Stereospecific quantitation of 6-prenylnaringenin in commercially available H. lupulus-containing natural health products and dietary supplementsView study →}. It is not a widespread plant constituent the way naringenin is — outside hops and hop-derived beverages it is rarely reported.

Discovery & Synthesis

6-PN was characterised as one of the minor prenylated flavanones of hops during the 1990s effort to map hop phenolics — the same body of work (Milligan, De Keukeleire, Stevens and colleagues) that identified 8-PN as the potent estrogen and clarified how both isomers arise from desmethylxanthohumol during brewing ^{1,10Reference 1Milligan SR et al. · 2000The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoidsView study →Reference 10Tronina T et al. · 2025Tronina T, Bartmańska A, Popłoński J, Rychlicka M, et al. (2025). 6-Prenylnaringenin — its beneficial biological effects and possible applications. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/41226696/View study →}. A dedicated de-novo total synthesis is not well documented; in practice 6-PN is obtained either by extraction from hops or, more cleanly, by semisynthesis from xanthohumol — Urmann et al. (2020) optimised a microwave-assisted demethylation of xanthohumol that yields a mixture of 6-PN and 8-PN in good combined yield, which is then separated ^{11Reference 11Urmann C · 2020Semi-synthetic approach leading to 8-prenylnaringenin and 6-prenylnaringenin: optimization of the microwave-assisted demethylation of xanthohumol using design of experimentsView study →}. Because the two isomers are produced together, efficient separation rather than construction of the skeleton is the practical manufacturing challenge.

Patents: not yet researched.

Toxicity & Safety

6-PN carries a low toxicity flag. It has been consumed by beer drinkers at microgram-per-litre levels for as long as hops have been used in brewing, with no signal of harm at those exposures, and — importantly — it lacks the strong estrogenicity that drives the main safety discussion around its sibling 8-PN ^{1Reference 1Milligan SR et al. · 2000The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoidsView study →}. Its own toxicity data are limited to cell culture, where cytotoxic effects appear only at high concentrations (≥10⁻⁴ M), well above dietary exposure ^{7Reference 7Effenberger KE et al. · 2005Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogensView study →}.

Safety at a Glance

✅ Low / no toxicity

• Low toxicity at dietary exposure. Long history of trace intake via beer; non-estrogenic, unlike 8-PN.
• Cytotoxic at high in-vitro concentrations. The same antiproliferative activity means cell-level toxicity appears at high micromolar/millimolar concentrations — a laboratory observation, not a dietary risk.
• No isolate safety dataset in humans. No repeat-dose, reproductive/developmental, or genotoxicity package exists for pure 6-PN; concentrated hop-supplement use has not been characterised for 6-PN specifically.

Dosage

There is no established human dose for isolated 6-prenylnaringenin. It is not sold as a stand-alone product. Real-world exposure is either dietary — beer, at roughly 1–240 µg/L ^{10Reference 10Tronina T et al. · 2025Tronina T, Bartmańska A, Popłoński J, Rychlicka M, et al. (2025). 6-Prenylnaringenin — its beneficial biological effects and possible applications. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/41226696/View study →} — or as a minor constituent of standardised hop extracts marketed for non-hormonal menopause support, where the standardisation target is usually 8-PN rather than 6-PN. All the concentrations cited above (typically tens of micromolar) are in-vitro experimental values, not intakes, and 6-PN’s poor oral bioavailability ^{5Reference 5van Breemen RB et al. · 2014Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hopsView study →} makes translating them to a dose speculative. These are research figures and not a personal recommendation.

References

1. Milligan SR, Kalita JC, Pocock V, Van de Kauter V, Stevens JF, Deinzer ML, Rong H, De Keukeleire D (2000). The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. Journal of Clinical Endocrinology & Metabolism. https://pubmed.ncbi.nlm.nih.gov/11134162/
2. Bartmańska A, Wałecka-Zacharska E, Tronina T, Popłoński J, et al. (2018). Highly cancer selective antiproliferative activity of natural prenylated flavonoids. Molecules. https://pubmed.ncbi.nlm.nih.gov/30423918/
3. Hitzman RT, Dunlap TL, Howell CE, Chen SN, Vollmer G, Pauli GF, Bolton JL, Dietz BM (2020). 6-Prenylnaringenin from hops disrupts ERα-mediated downregulation of CYP1A1 to facilitate estrogen detoxification. Chemical Research in Toxicology. https://pubmed.ncbi.nlm.nih.gov/32986415/
4. Bolton JL, Dunlap TL, Hajirahimkhan A, Mbachu O, et al. (2019). The multiple biological targets of hops and bioactive compounds. Chemical Research in Toxicology. https://pubmed.ncbi.nlm.nih.gov/30608650/
5. van Breemen RB, Yuan Y, Banuvar S, Shulman LP, et al. (2014). Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops. Molecular Nutrition & Food Research. https://pubmed.ncbi.nlm.nih.gov/25045111/
6. Teisseyre A, Palko-Labuz A, Uryga A, Michalak K (2018). The influence of 6-prenylnaringenin and selected non-prenylated flavonoids on the activity of Kv1.3 channels in human Jurkat T cells. Journal of Membrane Biology. https://pubmed.ncbi.nlm.nih.gov/30187077/
7. Effenberger KE, Johnsen SA, Monroe DG, Spelsberg TC, Westendorf JJ (2005). Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens. Journal of Steroid Biochemistry and Molecular Biology. https://pubmed.ncbi.nlm.nih.gov/16019205/
8. Monteiro R, Faria A, Azevedo I, Calhau C (2007). Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. Journal of Steroid Biochemistry and Molecular Biology. https://pubmed.ncbi.nlm.nih.gov/17643984/
9. Martinez SE, Davies NM (2015). Stereospecific quantitation of 6-prenylnaringenin in commercially available H. lupulus-containing natural health products and dietary supplements. Research in Pharmaceutical Sciences. https://pubmed.ncbi.nlm.nih.gov/26600844/
10. Tronina T, Bartmańska A, Popłoński J, Rychlicka M, et al. (2025). 6-Prenylnaringenin — its beneficial biological effects and possible applications. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/41226696/
11. Urmann C, Riepl H (2020). Semi-synthetic approach leading to 8-prenylnaringenin and 6-prenylnaringenin: optimization of the microwave-assisted demethylation of xanthohumol using design of experiments. Molecules. https://pubmed.ncbi.nlm.nih.gov/32887388/

View all 11 references▾